EDGAR Filing Documents for 0000947871-09-000320

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0000947871-09-000320

Filing Date

2009-04-14

Accepted

2009-04-14 10:27:27

Documents

Group Members

DOMINIQUE SEMONMERLIN BIOMED PRIVATE EQUITY ADVISORS, LLCMERLIN NEXUS II, L.P.NEXUS GEMINI, L.P.

Document Format Files

Seq	Description	Document	Type	Size
1		ss61253_sc13g.htm	SC 13G	160339
	Complete submission text file	0000947871-09-000320.txt		162466

Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500

SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81034 | Film No.: 09747860
SIC: 2834 Pharmaceutical Preparations

Mailing Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169

Business Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169 646-227-5270

Merlin BioMed Private Equity Advisors, L.L.C. (Filed by) CIK: 0001429303 (see all company filings)

IRS No.: 000000000
Type: SC 13G